[2P] Poster Presentation 2

[2P-783] A cap-dependent endonuclease inhibitor acts as a potent antiviral agent against La Crosse virus infection

○Kei Konishi^1,2, Yoshiyuki Taoda³, Manabu Igarashi², Takao Shishido¹, Kazuya Yasuo³, Yasuko Orba^4,5,2, Hirofumi Sawa^4,5, Michihito Sasaki^4,2, Akihiko Sato^1,2,4 (1. Laboratory for Drug Discovery & Disease Research, Shionogi & Co., Ltd., 2. International Institute for Zoonosis Control, Hokkaido University, 3. Laboratory for Medicinal Chemistry Research, Shionogi & Co., Ltd., 4. Institute for Vaccine Research and Development, Hokkaido University, 5. One Health Research Center, Hokkaido University)